Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4558701 | 0.81 | — | — | |
| SCHEMBL1930892 | 0.81 | — | — | |
| SCHEMBL25427959 | 0.80 | EPHX1 (0.33) | EPHX1 | |
| Ammonia Solution, Strong SCHEMBL2289542 | 0.78 | — | — | |
| SCHEMBL7747639 | 0.77 | — | — | |
| SCHEMBL18941455 | 0.77 | KDM4E (0.31) | — | |
| SCHEMBL28334131 | 0.75 | — | — | |
| SCHEMBL17427 | 0.75 | — | — | |
| SCHEMBL21296203 | 0.75 | — | — | |
| SCHEMBL484181 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| WO-2020015880-A1 | BI-PHASE DEODORIZING COSMETIC COMPOSITION | BEIERSDORF AG (DE) | 2020-01-23 | — | — | WO | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| US-20240240106-A1 | 1,4-BUTANEDIOL MONO- OR DIESTERS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2024-07-18 | — | — | US | disclosed |
| EP-3532018-B1 | USE OF 1-[(4R)-4-METHYLCYCLOHEXEN-1-YL]ETHANONE AS AN AROMA CHEMICAL | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-12023640-B2 | Aqueous dispersion of microcapsules, and uses thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | SYMRISE AG (DE) | 2024-07-02 | — | — | US | disclosed |
| US-20240209281-A1 | 2,4-DIMETHYLOCTA-2,7-DIEN-4-OL AS AN ODORIFEROUS SUBSTANCE | SYMRISE AG (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4387950-A1 | USE OF 1-(4- TERT- BUTYL CYCLOHEXYL) PROPYL ACETATE AS AROMA INGREDIENT | BASF SE (DE) | 2024-06-26 | — | — | EP | disclosed |
| US-12018227-B2 | Encapsulated fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-06-25 | — | — | US | disclosed |
| US-20240199519-A1 | ARYL/ALKENYL-PENTENAL DERIVATIVES AS AROMA CHEMICALS | BASF SE (DE) | 2024-06-20 | — | — | US | disclosed |
| WO-2002024857-A1 | MULTI-PHASE SOAP | HAARMANN & REIMER GMBH (DE) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002019983-A2 | CLEANSING/CONDITIONING AGENTS CONTAINING MATRIX PARTICLES WITH A PERFUME COMPONENT AND A WASHING-ACTIVE COMPONENT | HAARMANN & REIMER GMBH (DE) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002012157-A1 | NOVEL MACROCYCLIC KETONES | HAARMANN & REIMER GMBH (DE) | 2002-02-14 | — | — | WO | disclosed |
| US-20010005711-A1 | Perfume compositions comprising 4,8-dimethyl-3,7-nonadien-2-one | SYMRISE GMBH & CO. KG (DE) | 2001-06-28 | — | — | US | disclosed |
| EP-1111029-A2 | Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one | HAARMANN & REIMER GMBH (DE) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
| WO-2001038440-A1 | WAX FORMULATIONS CONTAINING ODORIFEROUS SUBSTANCES | HAARMANN & REIMER GMBH (DE) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001023373-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010005711-A1 | Perfume compositions comprising 4,8-dimethyl-3,7-nonadien-2-one | DEK, DPM1, DEGS1 | EPHX1 1577/4885 |
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | FAAH2, ADH5, NISCH | EPHX1 1023/4885 |
| US-20240199519-A1 | ARYL/ALKENYL-PENTENAL DERIVATIVES AS AROMA CHEMICALS | AHR, ARNT, TRPA1 | EPHX1 393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.